I am excited, thanks.

Collectively we investors, and the market which we collectively create, fail to recognize the significance of SAE reduction.

I know the horse is dead and beaten, but the reduction in the SAEs is in itself a clinically and statistically significant result. Thus I am dismayed, as it would is Dr. L at the “mixed response” of the market to the news (rather than mixed clinical results as some would have us believe).

SAE data release was certainly incomplete results. It still counts as part of the trial results.

Let’s see what DSMB finds this week.